Assessing Vulnerability and Outcomes of Intracranial Atherosclerotic Plaques

CompletedOBSERVATIONAL
Enrollment

3,849

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Asymptomatic Intracranial Atherosclerotic Stenosis Patients
Interventions
DIAGNOSTIC_TEST

Progression and Outcome of Intracranial Atherosclerosis

"Progression and Outcome of Intracranial Atherosclerosis is the primary endpoint; all others are secondary endpoints. Stroke defined as any stroke and new ipsilateral stroke (including ischemic and hemorrhagic stroke) associated with vascular stenosis."

Trial Locations (1)

100053

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
collaborator

The People's Hospital of Liaoning Province

OTHER

collaborator

The First Hospital of Jilin University

OTHER

collaborator

Jilin Electric Power Hospital

UNKNOWN

collaborator

Jilin city central hospital

UNKNOWN

lead

Xuanwu Hospital, Beijing

OTHER

NCT07156344 - Assessing Vulnerability and Outcomes of Intracranial Atherosclerotic Plaques | Biotech Hunter | Biotech Hunter